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Abstract The bi-functionai protein dimerization cofactor of 
HNF1 (DCoH)/pterin-4a-carbinolamine d hydratase (PCD) is 
found in liver cell nuclei bound to the transcription factor hepato- 
cyte nuclear factor 1 (HNF1) as well as in the cytoplasm acting 
as an enzyme involved in the phenylalanine hydroxylation system. 
Deficiency of DCoHIPCD activity in liver causes an atypical 
hyperphenylalaninemia and deficiency in human epidermis is re- 
lated to the depigmentation disorder vitiligo. DCoH/PCD from 
rat liver, which is identical to the human protein, was expressed 
in E. coli, purified to homogeneity and crystallized. The crystals 
belong to the trigonal space group P3121 (or P3221) with unit cell 
dimensions of a = b = 106.2oA, c = 197.1 A. Native crystals dif- 
fract to a resolution of 2.5 A. 
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1. Introduction 
Transcription factors are frequently observed to form homo- 
or heterodimers as a means to ensure specificity and regulatory 
control of their interaction with cognate DNA binding sites. 
The dimeric hepatocyte nuclear factor 1 (HNF1, also called 
LFB1 ) belongs to a family of homeodomain proteins and 
regulates the expression of many liver-specific and liver-en- 
riched genes (for reviews see [1 3]). 
DCoH was initially co-purified with the HNF1 from rat liver 
nuclear extracts. The sequence of the 104 amino acids was 
determined and the cDNAs from rat, mouse and human were 
cloned. The rat and human sequences are identical and differ 
in only one residue from that of mouse [4]. Immunoprecipita- 
tion experiments showed that DCoH binds to the dimerization 
domain of HNF1,  which is located in the 32 N-terminal amino 
acid residues. Stabilization of dimeric HNF1 and enhancement 
of its transcriptional ctivity were proposed functions of DCoH 
[3,4]. 
The cytoplasmic enzyme PCD, which is involved in the phen- 
ylalanine hydroxylation system, was isolated from rat and 
human liver cells, and the amino acid sequence was determined 
[5,6]. Surprisingly, the PCD sequence turned out to be identical 
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to DCoH, but no homology to any other protein could be 
detected [4-6]. The only observed difference between DCoH 
and PCD concerns their oligomerization state. PCD was found 
to form a homo-tetramer in solution [5,7], whereas DCoH was 
observed to bind as a dimer to the dimeric HNF1 [4]. The 
enzymatic function of PCD/DCoH is to catalyze the dehydra- 
tion of pterin-4c~-carbinolamine, which is formed in the tetrahy- 
drobiopterin dependent conversion of phenylalanine to tyro- 
sine. An atypical mild hyperphenylalaninemia ch racterized by 
an increased excretion of 7-biopterin in the urine of affected 
patients is related to a deficiency of PCD/DCoH activity [8-11]. 
In addition, patients with the depigmentation disorder vitiligo 
show a lack of PCD/DCoH activity in the affected epidermis 
[12]. 
Recently, a prokaryotic homologue of PCD/DCoH was dis- 
covered as part of the phenylalanine hydroxylase operon in 
Pseudomonas aeruginosa, where it apparently controls the ex- 
pression of phenylalanine hydroxylase [13]. 
In this paper, we report the overexpression, purification, and 
crystallization of tetrameric PCD/DCoH from rat as well as 
preliminary crystallographic results. 
2. Experimental 
2.1. Materials 
Kanamycin, DTT, Nonidet -P40, MES and CHES were obtained 
from Sigma, Pefabloc and IPTG were purchased from Boehringer and 
Saxon Biochemicals, respectively. All other chemicals were purchased 
from Merck. For column chromatography anFPLC system (Pharma- 
cia) was used. A plasmid containing the DCoH/PCD gene from rat liver 
was a generous gift from Dr. M. Yaniv, Paris. 
2.2. Protein purification 
DCoH/PCD was overexpressed in E. coli strain BL21 (DE3) from a 
pET9d plasmid. Cells were grown at 37 ° C in 5 1 of LB medium. At an 
A~00 of 1.2 the cells were induced with 1 mM IPTG for 2 h and harvested 
by centrifugation at 6000 x g for 30 min. All subsequent steps with 
exception of the gel filtration were done at 4°C and all buffers contained 
0.02% (w/v) sodium azide. 15 g wet cells were suspended ina lysis buffer 
containing 30 mM Tris-HCl (pH 7.8), 0.5% (v/v) Nonidet P-40, 2 mM 
EDTA, 1 mM Pefabloc and 2 mM DTT, and disrupted by sonication. 
The lysate was clarified by centrifugation at40,000 x g for 20 min, the 
supernatant again at 100,000 x g for 1.5 h. The 100,000 x g supernatant 
was subjected to an ammonium sulphate fractionation step. The pellet 
of the precipitation with 30% sat. ammonium sulphate was discarded 
and more ammonium sulphate was added to the supernatant togive a 
final saturation of 50%. The precipitate was pelleted and dissolved in 
25 ml buffer containing 20 mM Tris-HCl (pH 7.8), 1 mM EDTA and 
1 mM DTT and dialyzed against 5 1 of the same buffer overnight. The 
protein solution was loaded onto a Q-Sepharose Fastflow column 
(Pharmacia) equilibrated with buffer described above for the dialysis. 
The column was eluted with a linear gradient of 0 1.0 M NaCI. The 
DCoH/PCD containing fractions were desalted and concentrated by 
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ultra filtration using Centriprep-10 (Amicon). The protein was applied 
to a second anion exchange column (MonoQ HR 10/10, Pharmacia) 
equilibrated with the same buffer as for the Q-Sepharose column, this 
time at pH 7.0, and eluted with a linear (M).3 M NaC1 gradient. The 
DCoH/PCD fraction was concentrated to 10 mg/ml and applied to a 
Superdex 75 (26/60, Pharmacia) gel filtration column equilibrated in 20 
mM Tris/HC1 (pH 7.8), 1 mM DTT and 100 mM NaC1. The pure 
tetrameric DCoH/PCD was finally concentrated to 12 mg/ml in a Cen- 
tricon-10 (Amicon) and subsequently used for crystallization. 
2.3. Crystallization 
Crystallization was carried out by the hanging-drop vapour diffusion 
technique at 18 ° C. For initial crystallization experiments an automated 
fast screening crystallization protocol was applied using the described 
48 different crystallization conditions [14,15]. All reservoir solutions 
contained 2 mM DTT, 2 mM EDTA and 0.02% (w/v) sodium azide. 
Drops were prepared by mixing 2/A of DCoH solution (12 mg/ml) with 
2 ¢tl of the reservoir solution. First small needle like crystals grew in a 
droplet containing 2.0 M ammonium sulphate, 5% (v/v) MPD and 
CHES/NaOH (pH 9.5) and they diffracted to a resolution of about 3.5 
A.. The pH was screened over a range from 6.4 to 9.5, the concentration 
of ammonium sulphate optimized and the influence of MPD examined. 
The best crystals were obtained with a reservoir solution containing 
1.44 M ammonium sulphate buffered with 0.1 M MES-NaOH at pH 
6.4. 
2.4. X-ray difJ?action experiments 
Crystals were stabilized in 1.7 M ammonium sulphate, 0.1 M MES- 
NaOH (pH 6.4), 2 mM EDTA, 2 mM DTT and 0.02% (w/v) sodium 
azide, and mounted in thin walled glass capillary tubes. Diffraction data 
at 4 ° C were collected on a 300 mm MAR-research image plate system 
mounted on a rotating anode X-ray generator and on the prototype 220 
mm image plate system mounted on the EMBL beam line X31 at 
DESY, Hamburg, using synchrotron radiation. Data were processed 
using the program XDS [16]. Patterson self-rotation functions were 
calculated using the program POLARRFN [17] which is part of the 
CCP4 program suite [18]. 
3. Results and discussion 
The overexpression i E. coli and purification yielded 45 mg 
pure DCoH/PCD from 15 g wet cells. Gel fi ltration chroma- 
tography confirmed that DCoH/PCD exclusively exists as a 
homo-tetramer in solution as previously reported [5,7]. DCoH/  
PCD crystallizes in the presence of ammonium sulphate as the 
precipitating agent in the pH interval between pH 6.4 to pH 9.5. 
The best single crystals are obtained at pH 6.4 from drops 
containing 2¢tl of DCoH/PCD solution (12 mg/ml) mixed with 
2 yl  of the reservoir solution containing 1.44 M ammonium 
sulphate. Hexagonal  rod like crystals with dimensions up to 
0.3 x 0.3 x 0.8 mm grow within 2-3 days (Fig. 1). The crystals 
diffract to 2.5 A resolution. Native crystals are resistant o 
radiation damage and diffract strongly for at least 15 h in the 
X-ray beam. 
The space group and cell dimensions were determined to be 
Table l 
Data collection statistics and completeness of the data set 
Number of measured reflections 97383 
Number of unique reflections 34118 
R-sym 8.9% 
Completeness I > l0 a(1) I > 2 a(l) 
for data 15. 2.7 A 87.8% 81.5% 
for data 2.8 2.7/k 81.7% 68.6% 
R-sym = Yh Yi I I,h -- < Ih > I /Y.h~ i < l h >, where < Ih > is the mean 
intensity of the i observations of reflection h. 
Fig. 1. Crystal of dimerization cofactor of HNF1/pterin-4a- 
carbinolamin dehydratase. The crystal size is approximately 
0.25 x 0.25 x 0.5 mm. 
P3~21 (or the enant iomorph P3221) with a = b = 106.2 A and 
c = 197.1 A (~z =f l  = 90 °, y = 120°). The Matthews coefficient 
Vm assuming two tetramers or eight monomers (8 x 12 kDa) in 
the asymmetric unit is calculated to be 3.3 A3/Da which corre- 
sponds to a solvent content of 65% [19]. Equally consistent with 
the unit cell dimensions and space group symmetry is the pres- 
ence of three tetramers in the asymmetric unit corresponding 
to a Vm of 2.2 A~/Da and 45% solvent content. 
A complete native data set was collected from one crystal 
using synchrotron radiation at a wavelength of 1.0 A. To pre- 
vent overlap of reflections the crystal-to-detector distance had 
to be adjusted to 270 mm which limits the resolution to 2.6 
at the edge of the detector. Table 1 lists the data collection 
statistics and completeness of the processed ata set. 
Different symmetries are possible for a tetrameric protein. 
222 or 2 symmetry are most frequently observed, but proteins 
with fourfold symmetry, like neuramidase [20], are also known. 
To analyse local symmetry elements of the DCoH/PCD diffrac- 
tion data a self-rotation function was calculated in the resolu- 
tion range 10 to 3 A using an integration radius in Patterson 
space from 5 to 15 A. Several peaks for non-crystal lographic 
twofold (x = 180°), threefold (to = 120°), and fourfold 
Table 2 
Self-rotation peaks corresponding to two-, three- and four-fold axes 
K g2 q~ Height* 
180 90.0 0.0 100.0 (7.0 a)** 
180 90.0 90.0 58.8 (4.1 a) 
180 0.0 0.0 58.8 (4.1 a) 
180 34.8 90.0 27.4 (1.9 a) 
180 55.2 30.0 27.4 (1.9 a) 
120 0.0 0.0 100.0 (7.0 at** 
120 70.5 90.0 27.2 (1.9 a) 
90 0.0 0.0 56.9 (4.0 a) 
90 54.3 30.0 27.3 (1.9 a) 
Polar angles used by the program POLARRFN are defined as D: angle 
from pole, q~: angle around equator, x: rotational angle. 
*Self-rotation peaks are scaled to a maximum value of 100. The RMS 
deviation of the mean density (a) is 14.2. 
**These peaks represent crystallographic symmetry axes. 
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(Ic = 90 °) axes are found (Table 2), but the exact molecular 
symmetry still remains ambiguous. For space group P3121 self- 
rotation peaks corresponding to local two-, three- and fourfold 
axes are consistent with tetramers having a symmetry of either 
2 or 222 or 4 [21]. 
The determination of the crystal structure of DCoH/PCD 
will require the method of multiple isomorphous replacement, 
since a recent sequence alignment search with the rat DCoH/ 
PCD sequence yielded no homology to any protein of known 
three-dimensional structure. 
The X-ray structure analysis of DCoH/PCD should provide 
insight into the catalytic mechanism of its enzymatic function, 
the possible structural basis for hyperphenylalaninemia and 
vitiligo related to DCoH/PCD deficiency, and the mode of 
interaction with the transcription factor HNF1. 
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